X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-19 | AGIG | Abundia Global Impact Group, Inc. | Gillespie Edward Oliver | CEO | P - Purchase | $1.85 | +38,461 | 38,461 | New | +$71,261 | |||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Haas G Hunter IV | CFO, 10% | P - Purchase | $1.55 | +192,247 | 1,491,517 | +15% | +$297,983 | ||||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Cauley Robert E | CEO, 10% | P - Purchase | $1.55 | +192,248 | 1,560,215 | +14% | +$297,984 | ||||||
2025-12-26 | MNPR | Monopar Therapeutics | Vu Quan Anh | CFO | P - Purchase | $69.95 | +1,500 | 1,500 | New | +$104,925 | ||||||
2025-12-19 | PLX | Protalix Biotherapeutics, Inc. | Bashan Dror | Pres, CEO | P - Purchase | $1.81 | +56,000 | 2,532,934 | +2% | +$101,360 | ||||||
2025-12-23 | UPXI | Upexi, Inc. | Marshall Allan | CEO | P - Purchase | $1.80 | +50,000 | 4,046,261 | +1% | +$90,000 | ||||||
| M | 2025-12-22 | WHF | Whitehorse Finance, Inc. | Aronson Stuart D | CEO | P - Purchase | $6.86 | +17,000 | 67,000 | +34% | +$116,600 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |